Black Tie Intedrnational Magazine 
Select your preferred language
Celebrity Philanthropy News
Society News
Save the Date 2024
Black Tie
International Real Estate
Joyce Brooks
Gerard Mc Keon
Nightlife with Rose Billings
Dr. Judy Kuriansky
Meera Gandhi
Black Tie  TV
Impact Investment
Featured Foundations
Co-Hosting Events
Listing Non-Profit Events
Black Tie China
Black Tie France
Black Tie Israel
Black Tie Philippines
New York Society
Palm Beach Society
International Society
Hampton Society
West Coast Society
U.S. Society
Philanthropy  Giving
Entrepreneurial & Philanthropy Awards
Event Resource Directory
Promote your Services
Event Talent Directory
Feature Your Talent
Couture Fashion
Fine Wines
 Health & Wellness
Interior Design
Investigative Services
Kids on Location
Legal Services
Luxury Yachts
Pet Services
Private Air
 Real Estate
Recommended Reading
Restaurant Reviews
Single Friendly Events
Social Announcements
Sustainable Investment
Wealth Management
Add your e-mail
of Black Tie

Black Tie Classic
George Clooney
Princess Diana
Back Issues
More Back Issues

























































































































































































































































































































































Black Tie Health and Wellness 1

E-mail this link to your Friends

Black Tie International Magazine:Wellness -Dr. Terry Beardsley

Dr. Terry Beardsley

Dr. Terry Beardsley

USDA-approved Feline Leukemia Virus

and Feline

Immunodeficiency Virus Treatment

 Now Available


Murrieta, CA (December 29, 2011)…Dr. Terry Beardsley, founder and principal clinical researcher behind LTCI, the first USDA-approved treatment for Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) announced the launch of a new website and a simplified process for veterinarians to order Lymphocyte T-Cell Immunomodulator (LTCI) to treat their patients.

FeLV and FIV infections are two of the most common and fatal feline diseases worldwide. Infections can cause severe immune suppression and anemia and result in increased risk of other infections. LTCI is the first, and only, approved treatment aid in the United States for cats suffering from FeLV and FIV infections.

There was no effective treatment of these diseases or their symptoms until LTCI was granted a conditional license by the USDA. Veterinarians could only prescribe palliative care, isolation, and ultimately, euthanasia. LTCI is able to enhance the immune status of FeLV/FIV-infected cats with a corresponding, significant improvement in clinical symptoms. The therapeutic effects appear to be long-lasting, and without any side effects. 

T-Cyte Therapeutics’ website,, and new online capabilities mean that both pet owners and veterinarians can keep up-to-date on advances in the care and treatment of FeLV and FIV, and animal clinics can directly order and manage timely shipments of LTCI, particularly in cases of critically ill patients. The site also features educational and product information on retroviral health care and plans to add a searchable database of veterinary clinics across the country that offer LTCI for cats with FeLV and/or FIV.

“We’ve worked hard to build a website that streamlines access to pertinent, practical and accurate information regarding the treatment of these heretofore untreatable diseases [FeLV and FIV] and give veterinarians direct source access to LTCI. will be an efficient, factual resource for both pet owners and veterinarians,” said Dr. Beardsley. “The site will make it easier for pet owners to locate local veterinarians who treat cats suffering from these terrible maladies; the website will be a one-stop data source to aid in the treatment of FeLV and FIV.”


About T-Cyte Therapeutics:

T-Cyte Therapeutics ( is dedicated to providing safe, effective, science-based products that enhance the health of animals, allowing owners to enjoy their longer-lived and healthier animals.

In the worldwide medical community's scramble to find a cure for the deadly HIV/AIDS pandemic, scientists used the Feline Leukemia Virus (FeLV) and Feline Immunodeficiency Virus (FIV) as research models for the human diseases. Advances in understanding the immune system were moving at break-neck speed.

Even before this all-out race, Dr. Terry Beardsley, as a graduate researcher specializing in immunology at Baylor College of Medicine, had set out to discover a biological treatment pathway that emulated the body's own, natural defense processes, a discovery that could reverse the fatal effects of severe combined immune deficiency disease (SCID). This work resulted in a better understanding of bone marrow transplantation and the function of the thymus gland.

While a faculty member at UCLA, Dr. Beardsley demonstrated, that retrovirus infection alters the structure of the thymus gland and its ability to produce mature functional T-Cells; that retrovirus infection of thymic epithelial cells caused defective T-Cell development, leading to immune deficiency and/or leukemia. He ultimately proved that the destruction of thymic epithelium is a major contributor to failure of immune regeneration in AIDS.

At the University of California, Dr. Beardsley refined this cellular theory and was the first to clone thymic epithelial cells, successfully identifying and describing one of the immunoregulatory proteins involved in the process and the type of cells that produced it. That peptides extracted from thymus gland cells could control the immune system's response to viral attack, culminated in a landmark publication of Dr. Beardsley's research findings in The Proceedings of the National Academy of Science. With anti-HIV drug cocktails promising hope for HIV/AIDS patients, Dr. Beardsley studies had shown that his Lymphocyte T-cell Immunomodulator (LTCI) molecule could be used as a therapy for the treatment of immuno-compromised cats. He formed T-Cyte Therapeutics, Inc. to develop LTCI to treat the devastating effects of FeLV and FIV viruses in cats.






Joyce Brooks Jewellery


Black Tie  International Philanthropy

Meera Gandhi

Featured Save the Date


International Polo Charity Ball


Black Tie International Realty


Featured Foundation


Peace Angel Project

avazoo logo

Launch of the First
Billion Dollar Charity Raffle


Couture Fashion


Bridal Store


Black Tie Gift Selection


Black Tie Gift Selection


Featured Art


 Society News

Ocean emergency

Black Tie Magazine Gala
Carnegie Hall Opening Night
Casirta Maria
Zodiac Ball
Eliabeth Taylor Gala
Texas Heart Institute
Womens Foundation Gala
Meera Ghandi

Pamea Anderson


Prince Albert Gala


Featured Foundations

chuck feeney

Search the Site



Impact Investment

carbon geocycle

Black Tie China

lang lang foundation

Black Tie Philippines

City in a forest
black tie philippines

Nightlife with Rose Billings

Met Gala
sara Johnson
debutante Ball
Judy Kuriansky
Gerard Mc Keon

Celebrity Philanthropy News

sera Vergera
nicole Kidnman, jennifer Aniston
jean shafiroff, paul mc cartney
princess margaret of kent
Al Pacino, American Icon Awards
clive davis
american hospital of paris foundation
french heritage society
lupus research alliance
un women for peace
ben kingsley
ceylon tea party
Blavk Tie Gala
joyce brooks
central park conservatory
UN Correspondents Association
cardinal dolan
palm beach heart ball
vienese opera ball
lady in red gala
sanford stem cell
weizmann institute
carlos slim
israel 65th anniversary

Black Tie International Realty

secret paradise resort

Event Resources Directory

event resource directory



Copyright 2006 Black Tie Magazine. All Rights Reserved .

Privacy Policy |